Core Viewpoint - The company, Chenming Paper (01812), has experienced a significant stock price decline, triggering abnormal trading conditions as per Shenzhen Stock Exchange regulations [1] Group 1: Stock Performance - The company's B-share stock (code: 200488, abbreviation: ST Chenming B) saw a cumulative closing price drop of over 12% across three consecutive trading days from August 4 to August 6, 2025 [1] Group 2: Financial Developments - A special syndicate loan of 2.31 billion yuan designated for resuming production has been approved and is in the process of meeting withdrawal conditions and signing loan agreements [1] - The company plans to gradually resume operations at its production bases based on funding status and market conditions [1] Group 3: Disclosure and Compliance - The board of directors confirmed that there are no undisclosed matters that should be reported according to the Shenzhen Stock Exchange listing rules, nor any related plans, negotiations, or agreements [1] - The board has not been made aware of any undisclosed information that could significantly impact the trading price of the company's stock and its derivatives [1] - There are no corrections or supplements needed for previously disclosed information [1]

证券代码：603389 证券简称：*ST 亚振 公告编号：2025-069 亚振家居股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 证券停复牌情况：适用 因重大事项,亚振家居股份有限公司（以下简称"公司"）的相关证券停牌情 况如下： 停牌 公司股票交易连续三个交易日内日收盘价格涨幅偏离值累计达 12%，根据《上 海证券交易所交易规则》的相关规定，属于股票交易异常波动的情形。 证券代码 证券简称 停复牌类型 停牌起始日 停牌终止日 复牌日 期间 ? 公司股票于 2025 年 8 月 4 日、5 日、6 日连续三个交易日内日收盘价格涨幅偏 离值累计达到 12%，属于股票交易异常波动。 ? 公司股票于 2025 年 7 月 30 日至 8 月 6 日收盘价格涨幅偏离值累计达到 33.92%。 公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。为维护投资者利 益，公司将就股票交易情况进行核查。经申请，公司股票自 2025 年 8 月 7 日开市 起停牌，自披露核查公告后复牌，预计停牌时间不超过 ...

恒宇信通发布公告，公司股票连续三个交易日收盘价格涨幅偏离值累计达到42.44%（超过30%），根据 深圳证券交易所的相关规定，属于股票交易异常波动的情形。经核实，公司目前经营正常，近期经营情 况及内外部经营环境未发生重大变化。公司、控股股东以及实际控制人不存在关于公司应披露而未披露 的重大事项，或处于筹划阶段的重大事项。公司未发现前期披露的信息存在需要更正、补充之处。 ...

倍加洁8月6日公告，公司股票价格连续三个交易日内日收盘价格涨幅偏离值累计超过20%，属于股票交 易异常波动情形。经核实，公司生产经营情况正常，内外部经营环境未发生重大变化，不存在应披露而 未披露的重大事项。公司存在控股股东、实际控制人的一致行动人减持股份计划，减持计划尚未执行完 毕。公司市盈率高于行业平均水平，股价短期波动较大，提醒投资者注意投资风险。 ...

再到8月4日晚间，上纬新材公告称，经向上海证券交易所申请，公司计划自8月5日开市起复牌。复牌当 天，上纬新材股价再度涨停，收报110.48元/股。至此，上纬新材股价自2025年7月9日至2025年8月5日累 计涨幅已达1320.05%，7次触及股票交易异常波动情形，7次触及股票交易严重异常波动情形。 值得注意的是，8月5日晚，上交所发布情况通报，暂停上纬新材部分投资者账户交易。上交所表示，上 纬新材近期多次出现严重异常波动情形，公司已多次发布风险提示公告，提请广大投资者审慎投资，注 意投资风险。近日，该股股价继续大幅波动，部分投资者在交易该股过程中存在影响市场正常交易秩 序、误导投资者正常交易决策的异常交易行为，上交所依规对相关投资者采取了暂停账户交易的自律监 管措施。 复牌的第二天8月6日，上纬新材突遭跌停，截至发稿，上纬新材下跌20%，每股88.38元。 早在7月30日晚间，上纬新材披露公告称，公司股票价格自7月9日至7月30日期间多次触及股票交易异常 波动及严重异常波动情形，公司将就股票交易波动情况进行停牌核查。 ...

Core Viewpoint - The stock of Shangwei New Materials experienced significant volatility, with a sharp decline of over 17% on August 6, 2025, following a previous surge that saw its price increase by 1320.05% from July 9 to August 5, 2025, raising concerns about market stability and investor behavior [1][4]. Group 1: Stock Performance - On August 6, 2025, Shangwei New Materials opened with a drop exceeding 16%, hitting a trading halt and closing down over 17%, with trading volume surpassing 14 billion yuan [1]. - The stock had previously reached a record high of 110.48 yuan, marking a year-to-date increase of 1560%, making it the first stock in A-shares to exceed a 15-fold increase in 2025 [2]. - The stock's price fluctuations have led to a market capitalization of 135.7 billion yuan and a price-to-earnings ratio of 384.2 [2]. Group 2: Regulatory Actions and Warnings - The Shanghai Stock Exchange issued multiple warnings regarding the abnormal trading behavior of Shangwei New Materials, advising investors to exercise caution [4]. - The company has repeatedly disclosed trading risks, highlighting the potential for significant price volatility and the lack of substantial changes in its business operations or market conditions [4][5]. - The stock has been under close monitoring by the exchange, with 11 risk disclosures made and a temporary trading halt implemented for three days to assess the situation [5]. Group 3: Business Operations - Shangwei New Materials continues to focus on the research, production, and sales of environmentally friendly high-performance corrosion-resistant materials, wind turbine blade materials, new composite materials, and circular economy materials, with no significant changes reported in its operations [4]. - The company is currently undergoing a control change transaction, which requires compliance confirmation from the Shanghai Stock Exchange and may face uncertainties regarding the completion of share transfer procedures [5].

Core Viewpoint - Jiangsu Lianhuan Pharmaceutical Co., Ltd. experienced significant stock price fluctuations, with a cumulative closing price increase exceeding 20% over three consecutive trading days in early August 2025, prompting an announcement regarding abnormal trading activity [2][3]. Summary by Sections Stock Trading Abnormality - The company's stock price increased by over 20% cumulatively on August 1, 4, and 5, 2025, which is classified as abnormal trading activity according to the Shanghai Stock Exchange rules [2][3]. Company Operations and Major Events - A self-inspection revealed that the company's production and operations are normal, with no significant changes in market conditions or internal operations [4]. - The company confirmed that there are no undisclosed major events, such as asset restructuring or significant transactions, involving its controlling shareholders or actual controllers [5]. Media Reports and Market Rumors - The company found no significant events that could impact its stock price, nor any media reports or market rumors that require clarification [6]. Other Price-Sensitive Information - No other major events that could significantly affect the company's stock price were identified, and there were no stock trading activities by the controlling shareholders or management during the abnormal trading period [7]. Financial Performance - The company expects a net profit loss for the first half of 2025, estimating a range of -45 million to -38 million RMB, representing a decrease of 100.89 million to 107.89 million RMB compared to the same period last year, indicating a shift from profit to loss [2][12].

Core Viewpoint - Zhejiang Zhengyu Industrial Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days in early August 2025, which is classified as abnormal trading activity according to Shanghai Stock Exchange regulations [2][4]. Group 1: Stock Trading Abnormality - The company's stock price increased significantly on August 1, 4, and 5, 2025, leading to a cumulative price deviation of over 20% [2][4]. - The company conducted a self-examination and confirmed that there were no undisclosed significant information related to the stock price fluctuation [5]. Group 2: Business Performance - The company reported that its production and operational conditions remain normal, with no significant changes in the internal or external business environment [5]. - For the first half of 2025, the company expects a net profit attributable to shareholders of approximately 118.36 million yuan, representing a year-on-year increase of about 420.05% [5]. - The expected net profit after deducting non-recurring gains and losses is approximately 68.69 million yuan, reflecting a year-on-year increase of about 268.62% [5]. Group 3: Major Events and Information - As of the announcement date, the company confirmed that there were no undisclosed major events, except for the previously disclosed plan to issue shares to specific targets [6]. - The company did not identify any media reports or market rumors that could significantly impact its stock price [7]. - There were no other significant events that could affect the company's stock price during the abnormal trading period [8]. Group 4: Board Statement - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to stock listing rules, aside from the previously mentioned share issuance [12].

证券代码：603089 证券简称：正裕工业 公告编号：2025-065 ? 公司敬请广大投资者理性投资，注意二级市场交易风险。 一、股票交易异常波动的具体情况 本公司股票于 2025 年 8 月 1 日、8 月 4 日、8 月 5 日连续三个交易日收盘价 格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的有关规定，属 于股票交易异常波动。 二、公司关注并核实的相关情况 浙江正裕工业股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 浙江正裕工业股份有限公司（以下简称"公司"或"本公司"）股票于 超过 20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波 动。 ? 经公司自查，并向公司控股股东及实际控制人发函询证，截止本公告披 露日，确认不存在应披露而未披露的重大信息。 经公司自查，公司未发现对公司股票交易价格可能产生重大影响的或需澄清、 回应的媒体报道或市场传闻，亦未涉及市场热点概念。 （四）其他股价敏感信息 经公司自查，公司未发现其他可能对公司股价产生较大影响的 ...

Core Viewpoint - The stock of Upwind New Materials (688585) has experienced a significant price increase of 1320.05% from July 9 to August 5, leading to multiple warnings from the Shanghai Stock Exchange regarding abnormal trading behavior and potential risks for investors [3][5]. Group 1: Stock Performance and Trading Behavior - Upwind New Materials' stock price has shown severe volatility, prompting the Shanghai Stock Exchange to issue multiple risk alerts and take self-regulatory measures against certain investors for abnormal trading activities [2][5]. - The stock's trading volume has significantly increased, with an average turnover rate of 6.29% and a median of 5.67% from July 22 to August 5, which is notably higher than previous levels [6][7]. Group 2: Company Fundamentals and Valuation - Despite the dramatic increase in stock price, the company's fundamentals remain unchanged, with no significant alterations in its main business areas, including the development and production of environmentally friendly materials [5][7]. - As of August 5, the company's price-to-earnings (P/E) ratio stands at 502.51, which is substantially higher than the industry average of 24.91 [5][7]. Group 3: Control Change and Future Risks - The company announced a potential change in control, with Shanghai Zhiyuan Hengyue Technology Partnership set to acquire a controlling stake, although this process carries significant uncertainty regarding regulatory approvals [5][6]. - The company has continuously disclosed risks associated with its stock, including the disconnection between stock price and fundamentals, declining performance, and the lack of clear asset injection plans from the acquirer [7].